Aequus Pharmaceuticals's total assets for Q3 2024 were C$858.02K, a decrease of -14.99% from the previous quarter. TSE:AQS total liabilities were C$7.08M for the fiscal quarter, a 6.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.